Potentiation of warfarin by interferon.
作者信息
Adachi Y, Yokoyama Y, Nanno T, Yamamoto T
机构信息
Kinki University School of Medicine, Osaka, Japan.
出版信息
BMJ. 1995 Jul 29;311(7000):292. doi: 10.1136/bmj.311.7000.292a.
Abstract
摘要
相似文献
1
Potentiation of warfarin by interferon.干扰素对华法林的增效作用。
BMJ. 1995 Jul 29;311(7000):292. doi: 10.1136/bmj.311.7000.292a.
2
Warfarin potentiated by proguanil.乙胺嘧啶增强华法林的作用。
BMJ. 1991 Sep 28;303(6805):789.
3
Possible increased anticoagulation effect of warfarin induced by azithromycin.阿奇霉素诱导华法林抗凝作用可能增强。
Ann Pharmacother. 1998 Feb;32(2):269-70. doi: 10.1345/aph.17165.
4
[The effect of Tavan (SP-54) on the coagulation mechanism and fibrinolysis in patients receiving anticoagulant therapy].[塔万（SP - 54）对接受抗凝治疗患者凝血机制和纤维蛋白溶解的影响]
S Afr Med J. 1969 Dec 13;43(49):1504-7.
5
[Therapy of chronic viral hepatitis with interferon].
Internist (Berl). 1994 Jan;35(1):70-7; discussion 77-9.
6
Why did the response to warfarin change?对华法林的反应为何发生了变化？
RN. 2000 Dec;63(12):107.
7
[Interferon therapy in chronic viral hepatitis?].[慢性病毒性肝炎的干扰素治疗？]
Dtsch Med Wochenschr. 1993 Feb 19;118(7):240.
8
[Interferon in chronic hepatitis].[慢性肝炎中的干扰素]
Med Clin (Barc). 1991 Nov 23;97(18):700-2.
9
Interferon-induced thrombocytopenia: is it time for thrombopoietin.干扰素诱导的血小板减少症：是时候使用血小板生成素了吗？
Hepatology. 1998 Nov;28(5):1430-2. doi: 10.1002/hep.510280536.
10
[A case report on severe coagulations dysfunction induced by interaction of Warfarin and gestgestrinone].[华法林与孕三烯酮相互作用致严重凝血功能障碍1例报告]
Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Dec;42(12):1055.
引用本文的文献
1
Contraception in Myeloproliferative Neoplasms: A Pharmacological Review.骨髓增殖性肿瘤中的避孕：药理学综述
Eur J Haematol. 2025 Oct;115(4):344-348. doi: 10.1111/ejh.70014. Epub 2025 Jul 28.
2
Relationships, Current Issues, Safety and Efficacy of Oral Anticoagulation in Cancer Patients with Atrial Fibrillation.癌症合并心房颤动患者口服抗凝治疗的关系、当前问题、安全性及疗效
J Clin Med. 2023 Oct 16;12(20):6559. doi: 10.3390/jcm12206559.
3
Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature.炎症对成人细胞色素P450活性的影响：文献系统综述
Front Pharmacol. 2021 Nov 16;12:733935. doi: 10.3389/fphar.2021.733935. eCollection 2021.
4
Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report.华法林与博赛匹韦相互作用导致国际标准化比值低于治疗水平：一例病例报告。
J Med Case Rep. 2014 Dec 17;8:433. doi: 10.1186/1752-1947-8-433.
5
Immunological response as a source to variability in drug metabolism and transport.免疫反应作为药物代谢和转运变异性的一个来源。
Front Pharmacol. 2012 Feb 10;3:8. doi: 10.3389/fphar.2012.00008. eCollection 2012.
6
Interferon-beta treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity.干扰素-β治疗多发性硬化症患者不会改变CYP2C19或CYP2D6的活性。
Br J Clin Pharmacol. 2003 Sep;56(3):337-40. doi: 10.1046/j.0306-5251.2003.01859.x.
本文引用的文献
1
Depression of drug-metabolizing activity in the human liver by interferon-beta.
Hepatology. 1993 Jan;17(1):65-9.
2
Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450.
Biochem Pharmacol. 1984 Dec 1;33(23):3899-902. doi: 10.1016/0006-2952(84)90058-3.
3
Inhibition of theophylline metabolism by interferon.干扰素对茶碱代谢的抑制作用。
Lancet. 1987 Oct 24;2(8565):939-41. doi: 10.1016/s0140-6736(87)91422-x.
4
The effect of warfarin on mortality and reinfarction after myocardial infarction.华法林对心肌梗死后死亡率及再梗死的影响。
N Engl J Med. 1990 Jul 19;323(3):147-52. doi: 10.1056/NEJM199007193230302.
5
Depression of drug metabolizing activity in the human liver by interferon-alpha.
Eur J Clin Pharmacol. 1990;39(4):365-7. doi: 10.1007/BF00315411.
Zotero 插件